Red cells distribution width as a potential biomarker in COPD.

M. Marvisi (Cremona, Italy), S. Ramponi (Cremona, Italy), L. Balzarini (Cremona, Italy), C. Mancini (Cremona, Italy), C. Marvisi (Cremona, Italy)

Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session: Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session type: Thematic Poster
Number: 4454
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Marvisi (Cremona, Italy), S. Ramponi (Cremona, Italy), L. Balzarini (Cremona, Italy), C. Mancini (Cremona, Italy), C. Marvisi (Cremona, Italy). Red cells distribution width as a potential biomarker in COPD.. 4454

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Red cell distribution wide (RDW) as severity biomarker in patients with community-adquired pneumonia (CAP)
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012


Red cell distribution width value as a novel biomarker for exudative pleural fluid.
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Association between pulmonary function and red cell distribution width in a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001

Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Importance of meanplatelet volume, platelet distribution width and red blood cell distribution width in asthmatic subjects
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Prognostic value of red cell distribution width in patients with pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation?
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017


High « red cell distribution width » levels can predict  pulmonary embolism risk in multiple trauma patients: a case control study.
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018


Correlation between red cell distribution width and disease severity and mortality in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Hypersensitivity Pneumonitis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Red cell distribution width (RDW): A new predictor for chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

The prognostic value of extended lung function characterization in COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Is the strength of the type-2 (T2) inflammatory biomarker signal important in determining the burden of disease in severe asthma (SA)?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012

The prognostic value of  Red cell distribution width(RDW) in acute pulmonary thromboembolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018